Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
go back to main search page
Accession:CHEBI:18313 term browser browse the term
Definition:A glycotriaosylceramide having alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucose as the trisaccharide component.
Synonyms:exact_synonym: N-[(2S,3R,4E)-1-{[alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
 related_synonym: Burkitt's lymphoma antigen, bla-CD77;   CTH;   D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide;   Formula=C37H66NO18R;   Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer;   Gal-alpha1->4LacCer;   Galalpha1-4Galbeta1-4Glcbeta1-1'ceramide;   Gb3;   Gb3Cer;   GbOSe3Cer;   Globotriosylceramide;   SMILES=[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O)O)O)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*;   Trihexosylceramide;   alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer;   alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer;   alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide;   ceramide trihexoside;   globoside Gb3Cer (d18:1(4E));   globotriaosylceramide;   globotrihexosylceramide
 alt_id: CHEBI:12310;   CHEBI:12948;   CHEBI:14310;   CHEBI:16839;   CHEBI:20962;   CHEBI:20969;   CHEBI:27113;   CHEBI:4148;   CHEBI:9719
 xref: CAS:71965-57-6 "ChemIDplus";   CAS:71965-57-6 "KEGG COMPOUND";   KEGG:C04737;   KEGG:G00093
 xref_mesh: MESH:C018549
 xref: MetaCyc:D-GALACTOSYL-14-D-GALACTOSYL-14-D-;   PMID:11437603 "Europe PMC";   PMID:11525645 "Europe PMC";   PMID:11946769 "Europe PMC";   PMID:12227795 "Europe PMC";   PMID:15113548 "Europe PMC";   PMID:1528196 "Europe PMC";   PMID:16120140 "Europe PMC";   PMID:1724444 "Europe PMC";   PMID:17258170 "Europe PMC";   PMID:17674039 "Europe PMC";   PMID:18176841 "Europe PMC";   PMID:18810447 "Europe PMC";   PMID:19655181 "Europe PMC";   PMID:20424866 "Europe PMC";   PMID:20623712 "Europe PMC";   PMID:2120125 "Europe PMC";   PMID:21252262 "Europe PMC";   PMID:21376640 "Europe PMC";   PMID:2448252 "Europe PMC";   PMID:2456994 "Europe PMC";   PMID:2500499 "Europe PMC";   PMID:2960671 "Europe PMC";   PMID:7691279 "Europe PMC";   PMID:7841803 "Europe PMC"


show annotations for term's descendants       view all columns           Sort by:
 
alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Abcb1a ATP binding cassette subfamily B member 1A JBrowse link 4 22,339,829 22,517,642 RGD:6480464
G Il1b interleukin 1 beta JBrowse link 3 121,876,256 121,882,637 RGD:6480464
G Tnf tumor necrosis factor JBrowse link 20 5,189,382 5,192,000 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19654
    role 19598
      biological role 19596
        antigen 109
          alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide 3
            alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N- acylsphingosine + 0
            alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/26:1(17Z)) 0
            alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-hexacosanoylceramide 0
            beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E)) 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19654
    subatomic particle 19650
      composite particle 19650
        hadron 19650
          baryon 19650
            nucleon 19650
              atomic nucleus 19650
                atom 19650
                  main group element atom 19531
                    p-block element atom 19531
                      carbon group element atom 19413
                        carbon atom 19405
                          organic molecular entity 19405
                            organic group 18331
                              organic divalent group 18321
                                organodiyl group 18321
                                  carbonyl group 18209
                                    carbonyl compound 18209
                                      carboxylic acid 17908
                                        carboacyl group 16930
                                          univalent carboacyl group 16930
                                            carbamoyl group 16610
                                              carboxamide 16610
                                                ceramide 95
                                                  oligoglycosylceramide 3
                                                    glycotriaosylceramide 3
                                                      alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide 3
                                                        alpha-D-Gal-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N- acylsphingosine + 0
                                                        alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/26:1(17Z)) 0
                                                        alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-hexacosanoylceramide 0
                                                        beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide(d18:1(4E)) 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.